Showing results (41-50 of 2,881) with videos related to
Sort By:
Pageof 289
Current Opinion in Investigational Drugs (London, England : 2000)|August 30, 2008
Apixaban, an oral, direct inhibitor of activated Factor XaEduard Shantsila, Gregory Y H LipExpert Review of Cardiovascular Therapy|May 11, 2007
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapyPuneet Kakar, Gregory Y H LipAnnals of Internal Medicine|January 1, 2024
In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 moHironori Ishiguchi, Gregory Y H LipAnnals of Internal Medicine|November 6, 2023
In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomesKatarzyna Nabrdalik, Gregory Y H LipStroke|October 15, 2015
Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS TrialKeitaro Senoo, Gregory Y H LipStroke|December 3, 2015
Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation: The AMADEUS TrialKeitaro Senoo, Gregory Y H LipBMJ Clinical Evidence|November 29, 2014
Atrial fibrillation (acute onset)Gregory Y H Lip, Stavros ApostolakisHeart Failure Clinics|September 24, 2013
Stroke prevention in atrial fibrillation in heart failureEduard Shantsila, Gregory Y H LipJournal of Atrial Fibrillation|May 13, 2017
Preventative Measures of Stroke in Patients With Atrial FibrillationAhmed Adlan, Gregory Y H LipRevista Espanola De Cardiologia (English Ed.)|July 1, 2018
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal DysfunctionMaria Mahmood, Gregory Y H LipPageof 289